Securing Market Uptake

SUMMARY

Your drug has been recommended by the Danish Medicines Council – but how do you ensure that it reaches the patients who need it?

In order to ensure rapid and efficient clinical implementation, it is necessary to understand the processes, stakeholders, incentives, and barriers in the Danish hospital system.

In other words, ensuring patient access during the entire life cycle of the drug requires both planning and strategic effort.

On this two day course, you gain in-depth knowledge of how to work with patient access, including the most important barriers and activities you can initiate, and how you can optimise results throughout the drug's life cycle.

Other course participants say

"The course was a fantastic opportunity to learn and engage with different kinds of stakeholders in our healthcare environment."

Evy Skovhaur, External Affairs Manager, Novartis Healthcare A/S

"Outstanding programme with highly competent teachers and great lectures. There was ample opportunity to ask questions and discuss the cases presented."

Jeanett Balle Jensen, Market Access Lead, Takeda Pharma A/S

Keywords

• Patient access

• Drug life cycle

• Market access

• Field market access

• Post launch activities